Back | Next |
home / stock / nvcr / nvcr message board
Subject | By | Source | When |
---|---|---|---|
Simply put, no. | jondoeuk | investorshub | 03/17/2023 11:46:11 PM |
Wow is $NWBO really a threat? | rick172 | investorshub | 03/17/2023 2:12:16 PM |
Hello everyone, I got back into $NVCR this | whosleftholdindabag | investorshub | 03/17/2023 1:39:37 PM |
Plug away - Fake device for cure?? Na.. | KIPK | investorshub | 02/08/2023 12:16:19 PM |
Novocure aims to plough a new field https://www.evaluate.com/vantage/articles/in | jondoeuk | investorshub | 02/03/2023 9:49:44 PM |
Why HyGro is so worried??. He spends lots | KIPK | investorshub | 01/24/2023 12:45:29 PM |
Better head in the sand than in a | KIPK | investorshub | 01/22/2023 3:30:45 PM |
Ignore it. | jondoeuk | investorshub | 01/20/2023 12:32:40 AM |
Today News: After a review of Novocures future | KIPK | investorshub | 01/19/2023 2:24:41 PM |
Why is this going down? | rick172 | investorshub | 01/17/2023 3:32:11 PM |
Crackheads love Optune. | CrashOverride | investorshub | 01/14/2023 11:29:15 PM |
Very Telling. The 6 officers combined sold over | KIPK | investorshub | 01/12/2023 4:42:24 PM |
Did anyone else read this telling post | abc1212 | investorshub | 01/12/2023 4:08:05 PM |
It's strange there's no activity on this board. | exwannabe | investorshub | 01/11/2023 8:26:50 PM |
It's strange there's no activity on this board. | rick172 | investorshub | 01/11/2023 3:54:43 PM |
How's it going? | Penny chatter | investorshub | 01/11/2023 3:40:56 PM |
The Big Short - SCAM alert- The heat | KIPK | investorshub | 01/11/2023 12:21:15 PM |
Anyone else think this thing is a high | Long and gone | investorshub | 01/10/2023 8:50:01 PM |
Did the CEO dump virtually his entire position? | DrHigh | investorshub | 01/10/2023 5:40:13 PM |
You got that Absolutely right norisknorewards.. | KIPK | investorshub | 01/10/2023 4:06:41 PM |
News, Short Squeeze, Breakout and More Instantly...
NovoCure Limited Company Name:
NVCR Stock Symbol:
NASDAQ Market:
2024-05-03 01:00:11 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q1 2024 Earnings Call May 02, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q1 2024 Earnings Call Transcript
Use of proceeds to fund working capital needs stemming from Novocure’s anticipated launch in non-small cell lung cancer and settle, upon maturity, Novocure’s convertible notes Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 milli...
Quarterly net revenues of $139 million, up 13% year-over-year, with 3,845 active patients on therapy as of March 31, 2024 Phase 3 METIS trial in brain metastases from non-small cell lung cancer met primary endpoint and will be presented as late-breaking abstract at ASCO 2024 LUNAR...